Literature DB >> 20083040

Sporadic ataxia with adult onset: classification and diagnostic criteria.

Thomas Klockgether1.   

Abstract

In most patients with adult-onset progressive ataxia, the condition manifests without an obvious familial background. The classification and correct diagnosis of such patients remain a challenge, because almost the entire spectrum of non-genetic and genetic causes of ataxia has to be considered. A wide range of potential causes of acquired ataxia exist, including chronic alcohol use, various other toxic agents, immune-mediated inflammation, vitamin deficiency, chronic leptomeningeal deposition of iron leading to superficial siderosis, and chronic CNS infection. Mutations in single genes can also underlie sporadic ataxia in adults. Finally, patients might have a sporadic degenerative disease, such as multiple system atrophy of cerebellar type or sporadic adult-onset ataxia of unknown aetiology. The definition of clinical criteria and delineation of characteristic MRI features have greatly facilitated the early and correct recognition of sporadic ataxias. In addition, specific serological and genetic markers are available that allow a definite diagnosis in many cases. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20083040     DOI: 10.1016/S1474-4422(09)70305-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  67 in total

1.  Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia.

Authors:  Brent L Fogel; Ji Yong Lee; Jessica Lane; Amanda Wahnich; Sandy Chan; Alden Huang; Greg E Osborn; Eric Klein; Catherine Mamah; Susan Perlman; Daniel H Geschwind; Giovanni Coppola
Journal:  Mov Disord       Date:  2012-01-27       Impact factor: 10.338

Review 2.  Clinical neurogenetics: autosomal dominant spinocerebellar ataxia.

Authors:  Vikram G Shakkottai; Brent L Fogel
Journal:  Neurol Clin       Date:  2013-07-30       Impact factor: 3.806

3.  Utilization of genetic testing prior to subspecialist referral for cerebellar ataxia.

Authors:  Brent L Fogel; Barbara G Vickrey; Jenny Walton-Wetzel; Eli Lieber; Carole H Browner
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-01

4.  Characterization of Cerebellar Atrophy and Resting State Functional Connectivity Patterns in Sporadic Adult-Onset Ataxia of Unknown Etiology (SAOA).

Authors:  Xueyan Jiang; J Faber; I Giordano; J Machts; Ch Kindler; A Dudesek; O Speck; Ch Kamm; E Düzel; F Jessen; A Spottke; St Vielhaber; H Boecker; T Klockgether; L Scheef
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

Review 5.  Consensus Paper: Neurophysiological Assessments of Ataxias in Daily Practice.

Authors:  W Ilg; M Branscheidt; A Butala; P Celnik; L de Paola; F B Horak; L Schöls; H A G Teive; A P Vogel; D S Zee; D Timmann
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

Review 6.  Milestones in ataxia.

Authors:  Thomas Klockgether; Henry Paulson
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 7.  The Contribution of the Cerebellum in the Hierarchial Development of the Self.

Authors:  Mehmet Emin Ceylan; Aslıhan Dönmez; Barış Önen Ülsalver
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

Review 8.  Diagnosis and differential diagnosis of MSA: boundary issues.

Authors:  Han-Joon Kim; Beom S Jeon; Kurt A Jellinger
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

9.  Downbeat nystagmus as an initial clinical sign in spinocerebellar ataxia type 6.

Authors:  Tatsuya Ueno; Hisanori Nishizawa; Chieko Suzuki; Jin-Ichi Nunomura; Masahiko Tomiyama
Journal:  Neurol Sci       Date:  2017-04-29       Impact factor: 3.307

10.  Genetic and clinical features of Chinese patients with mitochondrial ataxia identified by targeted next-generation sequencing.

Authors:  Hai-Lin Dong; Yin Ma; Quan-Fu Li; Yi-Chu Du; Lu Yang; Sheng Chen; Zhi-Ying Wu
Journal:  CNS Neurosci Ther       Date:  2018-05-13       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.